BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37169605)

  • 1. [Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Polomeni A; Ainaoui M; Berr A; de Bentzman N; Denis M; Friser V; Magro L; Yakoub-Agha I
    Bull Cancer; 2024 Feb; 111(2S):S67-S77. PubMed ID: 37169605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Yafour N; Couturier MA; Borel C; Charbonnier A; Coman T; Fayard A; Masouridi-Levrat S; Yakoub-Agha I; Roy J
    Bull Cancer; 2024 Feb; 111(2S):S29-S39. PubMed ID: 37045732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Yafour N; Beckerich F; Bulabois CE; Chevallier P; Daguindau É; Dumesnil C; Guillaume T; Huynh A; Levrat SM; Menard AL; Michallet M; Pautas C; Poiré X; Ravinet A; Yakoub-Agha I; Bazarbachi A
    Bull Cancer; 2017 Dec; 104(12S):S84-S98. PubMed ID: 29179894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfusion management and immuno-hematological follow-up after allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Xhaard A; Bouton M; Delugin L; Giraud C; Guyon A; Giroux-Lathuile C; Hajjout K; Nicolas P; Peyrard T; Ratie V; Boisnard A; Capelle L; Godin S; Traineau R; Yacoub-Agha I; Leprêtre AC
    Bull Cancer; 2024 Feb; 111(2S):S78-S83. PubMed ID: 37055307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of allogeneic hematopoietic cell transplantation after anti-CD19 CAR T-cell treatment: Guidelines from the SFGM-TC].
    Beauvais D; Castilla-Llorente C; Diral E; Sirvent A; Vandewiele A; Baruchel A; Yakoub-Agha I; Yakouben K
    Bull Cancer; 2023 Feb; 110(2S):S108-S115. PubMed ID: 35791974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Conrad A; Beguin Y; Guenounou S; Le Bourgeois A; Ménard AL; Rialland F; Layal S; Mamez AC; Yakoub-Agha I; El Cheikh J
    Bull Cancer; 2024 Feb; 111(2S):S40-S49. PubMed ID: 37479644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S106-S111. PubMed ID: 29169650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Loschi M; Alsuliman T; Cabrera Q; Desbrosses Y; Desmier D; Yakoub Agha I; Guillaume T
    Bull Cancer; 2024 Feb; 111(2S):S22-S28. PubMed ID: 36922321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
    Yakoub-Agha I
    Curr Res Transl Med; 2018 May; 66(2):57-58. PubMed ID: 29685843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute lymphoblastic leukemia in developing countries: Management from the transplant indication (allo/auto) until post-transplant follow-up. Guidelines from the SFGM-TC].
    Yafour N; Hamzy F; Elkababri M; Yakoub-Agha I; Bekadja MA
    Bull Cancer; 2023 Feb; 110(2S):S30-S38. PubMed ID: 35562231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].
    Zephir H; Puyade M; Gueguen A; Michel L; Terriou L; Dive D; Laureys G; Mathey G; Labauge P; Marjanovic Z; Pugnet G; Badoglio M; Lansiaux P; Yakoub-Agha I; Béguin Y; Farge D
    Bull Cancer; 2019 Jan; 106(1S):S92-S101. PubMed ID: 30527815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Palliative care in hematopoietic stem-cell transplanted patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Polomeni A; Prod'homme C; Ainaoui M; Bellec A; Berr A; Bonneau J; Charbonnier A; Coiteux V; de Berranger E; Descamps T; Gire M; Goncalves M; Ruscassié A; Yakoub-Agha I; Borel C
    Bull Cancer; 2021 Dec; 108(12S):S1-S9. PubMed ID: 34176584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second allogeneic hematopoietic stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Yafour N; Couturier MA; Azarnoush S; Girault S; Hermet E; Masouridi Levrat S; Schmidt A; Michallet M; Etancelin P; Guillaume T; Malard F; Sirvent A; Yakoub-Agha I; Poiré X
    Bull Cancer; 2019 Jan; 106(1S):S40-S51. PubMed ID: 30409466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S131-S135. PubMed ID: 29173980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-transplant neurological complications: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Hicheri Y; Buchbinder N; Magro L; Farah B; Zephir H; Brissot E; Yakoub-Agha I; Chevallier P
    Bull Cancer; 2019 Jan; 106(1S):S18-S22. PubMed ID: 30392709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haemorrhagic cystitis following hematopoietic stem cell transplantation: Prophylaxis, diagnosis, and treatment. Guidelines from the SFGM-TC].
    Dequirez PL; Magro L; Alsuliman T; Ceballos P; Desbrosses Y; Yakoub-Agha I; Guillaume T
    Bull Cancer; 2023 Feb; 110(2S):S48-S55. PubMed ID: 35181061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S121-S130. PubMed ID: 29173973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic hematopoietic cell transplantation for Hodgkin's disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S112-S120. PubMed ID: 29173978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Faucher C; Adam C; Bancillon N; Bertrand E; Colledani F; de Berranger E; Denis V; Girard I; Hamzy F; Loukili N; Mannone L; Mercier L; Perrin A; Vasseur A; Asma Q; Bompoint C; Yafour N; Yakoub-Agha I; Jost E
    Bull Cancer; 2019 Jan; 106(1S):S1-S9. PubMed ID: 30580913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Bay JO; Beguin Y; Carpentier A; Dard C; Guillaume T; Labussiere-Wallet H; Lacassagne MN; Sauze S; Yakoub-Agha I; Chalandon Y
    Bull Cancer; 2021 Dec; 108(12S):S20-S25. PubMed ID: 34215432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.